LUNG financials
Pulmonx (LUNG) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- LUNG revenue was $90.50M in fiscal 2025, net income -$54.00M.
LUNG income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $90.50M | $67.14M | -$53.66M | -$54.00M | -1.33 |
| 2024 | $83.79M | $62.00M | -$57.70M | -$56.39M | -1.44 |
| 2023 | $68.67M | $50.75M | -$61.94M | -$60.84M | -1.60 |
| 2022 | $53.66M | $39.87M | -$58.64M | -$58.92M | -1.59 |
| 2021 | $48.42M | $35.63M | -$47.30M | -$48.66M | -1.35 |
| 2020 | $32.73M | $21.20M | -$32.33M | -$32.23M | -3.16 |